Press "Enter" to skip to content

Molecular Diagnostics Market 2019: Comprehensive Analysis by Top Key Companies, Industry Growth, Size, Share, Market Insights, Sales Volume and Forecast to 2024


The “Molecular Diagnostics Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Molecular Diagnostics industry. The information available in the Molecular Diagnostics market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Molecular Diagnostics market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Molecular Diagnostics Market:

  • F. Hoffmann
  • la Roche Ltd
  • Illumina, Inc.
  • Hologic Corporation
  • Agilent Technologies / Dako
  • Qiagen
  • Myriad Genetics
  • BD (Becton, Dickinson And Company)
  • Abbott Laboratories
  • Cepheid Inc.
  • Genomic Health Inc.

    Get a Sample Copy of the Report –

    Market Overview:

  • The global molecular diagnostics market was valued at USD 7,854.45 million in 2018, and is estimated to be valued at USD 13,340.35 million by 2024, while witnessing a CAGR of 9.23% during the forecast period, 2019-2024. Factors that are responsible for the growth of the market include large outbreaks of bacterial and viral epidemics in the world, increasing demand for point-of-care diagnostics, recent advancements in pharmacogenomics, and rapidly evolving technology.
  • Molecular diagnostics is considered to be the best method to identify and characterize a microorganism. An effective test must be precise, rapid, and also be able to measure the infectious burden. Better testing quickly identifies the organism’s strain and drug susceptibility, thus, reducing the delay in finding the right antibiotic. Technological advancements, like a polymerase chain reaction (PCR), have also made it possible to identify the antimicrobial resistance genes and provide public health information, such as strain characterization by genotyping. The infectious disease segment currently records the highest growth in the molecular diagnostics market.

    Scope of the Report:

  • Molecular diagnostic tests detect specific sequences in DNA or RNA (including single nucleotide polymorphisms (SNP), deletions, rearrangements, insertions, and others), which may or may not be associated with diseases. Molecular diagnostics has been revolutionized over the past few decades. Currently, it is the driving force behind the transformation in healthcare, thus, leading to innovations in the field of molecular biology. These include next-generation sequencing, microarray technologies, liquid biopsies, early cancer detection, direct-to-consumer testing, and point-of-care assays.

    Reasons for Buying Molecular Diagnostics Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at –

    Key Market Trends:

    Instruments Sub-segment is Expected to Hold the Largest Market Share in the Product Segment

    In the product segment of the global molecular diagnostics market, the instruments sub-segment is believed to have the largest market size and is expected to witness a CAGR of 9.13% during the forecast period.

    Molecular diagnostics plays a vital role in the assessment of disease prognosis and therapy response, as well as in the detection of minimal residual disease. In the past decade, molecular diagnostics has grown, due to advances in the chemistries and instrumentation, including automation, integration, throughput, and the ability to use the instrumentation in a random-access mode.

    Some of the sophisticated instruments used in this market are High-performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and Nuclear Magnetic Resonance (NMR), along with real-time PCR, Enzyme-linked ImmunoSorbent Assay (ELISA), RadioImmunoAssay (RIA), lateral flow devices, patient safety syringes, point-of-care testing devices, and others.

    North America Dominates the Market and is Expected to do the Same over the Forecast Period

    North America currently dominates the molecular diagnostics market and is expected to continue its stronghold for a few more years. The United States accounts for the largest market share in the overall North American molecular diagnostics market. Molecular diagnostics has played a vital role in changing the face of disease diagnostics and assuring speedy detection and accurate care for critically ill patients. The increase in per capita health expenditures, the advancement in healthcare infrastructure, and the increase in the number of infectious diseases and cancer cases in the United States have led to a shift in trend from the traditional diagnostic methods to molecular diagnostics.

    In addition, rising technological advancements, increasing entry of new players, and speedy adoption of advanced molecular diagnostics, are helping in the growth of the market in the United States.

    Molecular Diagnostics Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) –

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Molecular Diagnostics Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Large Outbreaks of Bacterial And Viral Epidemics in the World
    4.2.2 Increasing Demand for Point-of-care Diagnostics
    4.2.3 Recent Advancements in Pharmacogenomics
    4.2.4 Rapidly Evolving Technology
    4.3 Market Restraints
    4.3.1 Limited Budgets for R&D and Economic Slowdown
    4.3.2 Need for High-complexity Testing Centers
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 Technology
    5.1.1 In Situ Hybridization
    5.1.2 Chips and Microarrays
    5.1.3 Mass Spectrometry (MS)
    5.1.4 Sequencing
    5.1.5 PCR
    5.1.6 Other Technologies
    5.2 Application
    5.2.1 Infectious Disease
    5.2.2 Oncology
    5.2.3 Pharmacogenomics
    5.2.4 Microbiology
    5.2.5 Genetic Disease Screening
    5.2.6 Human Leukocyte Antigen Typing
    5.2.7 Blood Screening
    5.3 Product
    5.3.1 Instruments
    5.3.2 Reagents
    5.3.3 Other Products
    5.4 End User
    5.4.1 Hospitals
    5.4.2 Laboratories
    5.4.3 Other End Users
    5.5 Geography
    5.5.1 North America United States Canada Mexico
    5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.5.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.5.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 F. Hoffmann-la Roche Ltd
    6.1.2 Illumina, Inc.
    6.1.3 Hologic Corporation
    6.1.4 Agilent Technologies / Dako
    6.1.5 Qiagen
    6.1.6 Myriad Genetics
    6.1.7 BD (Becton, Dickinson And Company)
    6.1.8 Abbott Laboratories
    6.1.9 Cepheid Inc.
    6.1.10 Genomic Health Inc.



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Electric Bike Market 2019 | Emerging Technologies by Size and Share, Key Players Analysis, Sales Revenue, Growth Status, Opportunity Assessment and Business Expansion Plans 2026

    Screen Protective Film Market 2019 Industry Size, Trends, Global Growth, Recent Developments and Latest Technology, Forecast Research Report 2024

    Connected Truck Market Analysis 2019 to 2025: Report Includes Threat of New Entrants, Demand & Supply, Investment Opportunities and Forecast

    Magnetic Resonance Imaging (MRI) Market 2019 Global Market Share, Leading Players Updates, Future Trends and Industry Growth Updates Forecast to 2024

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *